SCHEMBL13636978

SCHEMBL13636978

CCOP(=O)(OCC)c1ccc(S)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.43
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA4 P22748 1/20 0.40
CA5A P35218 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA5B Q9Y2D0 1/20 0.40
POLB P06746 2/20 0.39
HTR2A P28223 1/20 0.38
HTR2B P41595 1/20 0.38
ACHE P22303 1/20 0.38
NPSR1 Q6W5P4 2/20 0.37
TSHR P16473 3/20 0.37
KCNH2 Q12809 1/20 0.36
CCNT1 O60563 1/20 0.36
CDK9 P50750 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6829825 0.89 TDP1 (0.49) TDP1MEN1KMT2ACA12CA1
SCHEMBL9407115 0.83 TDP1 (0.45) TDP1MEN1KMT2ACA12CA1
SCHEMBL107781 0.81 HPGD (0.48) TDP1MEN1KMT2ACA12CA1
SCHEMBL914851 0.79 POLB (0.47) TDP1MEN1KMT2ACA12CA1
SCHEMBL6898817 0.79 TDP1 (0.43) TDP1MEN1KMT2ACA12CA1
SCHEMBL23057071 0.79 TDP1 (0.43) TDP1MEN1KMT2ACA12CA1
SCHEMBL3364776 0.79 GAA (0.47) TDP1MEN1KMT2ACA12CA1
SCHEMBL11140840 0.79 POLB (0.54) TDP1MEN1KMT2ACA12CA1
SCHEMBL13637001 0.79 TDP1 (0.43) TDP1MEN1KMT2ACA12CA1
SCHEMBL895236 0.79 ALDH1A1 (0.47) TDP1MEN1KMT2ACA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090292135-A1 ORGANOMETAL BENZENEPHOSPHONATE COUPLING AGENTS IRONWOOD PHARMACEUTICALS, INC. (US) 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090292135-A1 ORGANOMETAL BENZENEPHOSPHONATE COUPLING AGENTS ZNF207, TST, BOLA2; BOLA2B TDP1 3119/4885MEN1 1650/4885KMT2A 2095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.